Search Results - "Linge, Annett"
-
1
SLC3A2/CD98hc, autophagy and tumor radioresistance: a link confirmed
Published in Autophagy (03-10-2019)“…SLC3A2/CD98hc (solute carrier family 3 member 2) and its light chain subunits constitute the heterodimeric transmembrane complexes that mediate amino acid…”
Get full text
Journal Article -
2
Oct4 confers stemness and radioresistance to head and neck squamous cell carcinoma by regulating the homologous recombination factors PSMC3IP and RAD54L
Published in Oncogene (17-06-2021)“…Head and neck squamous cell carcinoma (HNSCC) is often being diagnosed at an advanced stage, conferring a poor prognosis. The probability of local tumor…”
Get full text
Journal Article -
3
The CD98 Heavy Chain Is a Marker and Regulator of Head and Neck Squamous Cell Carcinoma Radiosensitivity
Published in Clinical cancer research (15-05-2019)“…The heavy chain of the CD98 protein (CD98hc) is encoded by the gene. Together with the light subunit LAT1, CD98hc constitutes a heterodimeric transmembrane…”
Get full text
Journal Article -
4
Analysis of MRI and CT-based radiomics features for personalized treatment in locally advanced rectal cancer and external validation of published radiomics models
Published in Scientific reports (17-06-2022)“…Radiomics analyses commonly apply imaging features of different complexity for the prediction of the endpoint of interest. However, the prognostic value of…”
Get full text
Journal Article -
5
HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: Results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)
Published in Radiotherapy and oncology (01-12-2014)“…Abstract Objective To investigate the impact of HPV status in patients with locally advanced head and neck squamous cell carcinoma (HNSCC), who received…”
Get full text
Journal Article -
6
Type I conventional dendritic cells and CD8 + T cells predict favorable clinical outcome of head and neck squamous cell carcinoma patients
Published in Frontiers in immunology (13-06-2024)“…Head and neck squamous cell carcinoma (HNSCC) is one of the most common tumor entities worldwide, with human papillomavirus (HPV) infection contributing to…”
Get full text
Journal Article -
7
Development and Validation of a Gene Signature for Patients with Head and Neck Carcinomas Treated by Postoperative Radio(chemo)therapy
Published in Clinical cancer research (15-03-2018)“…The aim of this study was to identify and independently validate a novel gene signature predicting locoregional tumor control (LRC) for treatment…”
Get full text
Journal Article -
8
Prognostic biomarkers for the response to the radiosensitizer nimorazole combined with RCTx: a pre-clinical trial in HNSCC xenografts
Published in Journal of translational medicine (26-08-2023)“…Abstract Background Tumor hypoxia is associated with resistance to radiotherapy and chemotherapy. In head and neck squamous cell carcinoma (HNSCC), nimorazole,…”
Get full text
Journal Article -
9
Specific requirements for translation of biological research into clinical radiation oncology
Published in Molecular oncology (01-07-2020)“…Radiotherapy has been optimized over the last decades not only through technological advances, but also through the translation of biological knowledge into…”
Get full text
Journal Article -
10
Integrated radiogenomics analyses allow for subtype classification and improved outcome prognosis of patients with locally advanced HNSCC
Published in Scientific reports (06-10-2022)“…Patients with locally advanced head and neck squamous cell carcinoma (HNSCC) may benefit from personalised treatment, requiring biomarkers that characterize…”
Get full text
Journal Article -
11
Identification and Functional Validation of RAD23B as a Potential Protein in Human Breast Cancer Progression
Published in Journal of proteome research (03-07-2014)“…Identification of protein targets that play a role in breast cancer invasion may help to understand the rapid progression of cancer and may lead to the…”
Get full text
Journal Article -
12
Comparison of the composition of lymphocyte subpopulations in non-relapse and relapse patients with squamous cell carcinoma of the head and neck before, during radiochemotherapy and in the follow-up period: a multicenter prospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)
Published in Radiation oncology (London, England) (31-07-2021)“…Radiochemotherapy (RCT) has been shown to induce changes in immune cell homeostasis which might affect antitumor immune responses. In the present study, we…”
Get full text
Journal Article -
13
ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy
Published in The pharmacogenomics journal (01-02-2021)“…Identifying patients with locally advanced head and neck carcinoma on high risk of recurrence after definitive concurrent radiochemotherapy is of key…”
Get full text
Journal Article -
14
Correction: ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy
Published in The pharmacogenomics journal (01-04-2021)“…An amendment to this paper has been published and can be accessed via a link at the top of the paper…”
Get full text
Journal Article -
15
Immunohistochemical analyses of paraffin-embedded sections after primary surgery or trimodality treatment in esophageal carcinoma
Published in Clinical and translational radiation oncology (01-09-2022)“…•Changes in the tumor microenvironment of esophageal cancers, both in squamous cell carcinoma and adenocarcinoma, were found when comparing tumor resection…”
Get full text
Journal Article -
16
Independent validation of tumour volume, cancer stem cell markers and hypoxia-associated gene expressions for HNSCC after primary radiochemotherapy
Published in Clinical and translational radiation oncology (01-05-2019)“…•Tumour volume, p16 status and N stage could be validated regarding LRC and OS.•Addition of cancer stem cell markers can further improve the baseline…”
Get full text
Journal Article -
17
Definition and validation of a radiomics signature for loco-regional tumour control in patients with locally advanced head and neck squamous cell carcinoma
Published in Clinical and translational radiation oncology (01-01-2021)“…•A prognostic signature for LRC in locally-advanced HNSCC was developed and validated.•Signature development was based on advanced machine-learning…”
Get full text
Journal Article -
18
Successful immunotherapy and irradiation in a HIV-positive patient with metastatic Merkel cell carcinoma
Published in Clinical and translational radiation oncology (01-02-2019)“…•First report on PD-L1 therapy and radiotherapy in a HIV positive patient with metastatic Merkel cell carcinoma.•The patient has been tolerated the treatments…”
Get full text
Journal Article -
19
Downregulation of caveolin-1 affects bleomycin-induced growth arrest and cellular senescence in A549 cells
Published in The international journal of biochemistry & cell biology (2007)“…Bleomycin is an anti-cancer drug that induces both apoptosis and senescence, two processes thought to involve caveolin-1. Here we investigate the role of…”
Get full text
Journal Article -
20
Independent validation of the prognostic value of cancer stem cell marker expression and hypoxia-induced gene expression for patients with locally advanced HNSCC after postoperative radiotherapy
Published in Clinical and translational radiation oncology (01-12-2016)“…To validate the impact of HPV status, cancer stem cell (CSC) marker expression and tumour hypoxia status in patients with locally advanced head and neck…”
Get full text
Journal Article